BPC-157 + TB-500 Combination Peptide: The Ultimate Duo for Healing, Recovery, and Regeneration
Modern medicine continues to evolve, and nowhere is this more evident than in the world of peptide therapy. At Revolution Health & Wellness, we’re proud to offer a combination peptide that blends two of the most powerful healing agents into a single vial: BPC-157 and TB-500.
This synergistic pairing accelerates tissue repair, reduces inflammation, supports musculoskeletal recovery, and optimizes performance. For anyone recovering from injury, managing chronic inflammation, or optimizing recovery, this combination offers unmatched therapeutic potential.
What Are BPC-157 and TB-500?
BPC-157: The Body’s Healing Blueprint
BPC-157 (Body Protection Compound-157) is a pentadecapeptide (15 amino acids) derived from a protein found in human gastric juice. It’s known for promoting rapid healing in the gut, tendons, ligaments, muscles, nerves, and skin.
Its most notable mechanisms include:
-
Promoting angiogenesis (formation of new blood vessels)
-
Reducing pro-inflammatory cytokines
-
Enhancing fibroblast migration and tissue remodeling
-
Supporting gut barrier repair
TB-500: The Repair Accelerator
TB-500 is a synthetic version of a naturally occurring protein called Thymosin Beta-4 (Tβ4). This peptide plays a critical role in tissue regeneration, inflammation modulation, and cellular migration.
Its key functions include:
-
Facilitating cell migration to injury sites
-
Regulating actin for cell movement and structural repair
-
Reducing inflammatory cytokines
-
Supporting angiogenesis and wound healing
Why Combine BPC-157 and TB-500?
While each peptide is powerful on its own, their combination creates a synergistic effect. BPC-157 works locally at the site of injury to stimulate repair, while TB-500 works systemically to enhance cell mobility, boost recovery from the inside out, and accelerate healing across multiple tissues.
Together, they:
-
Promote faster healing from tendon, ligament, and muscle injuries
-
Reduce inflammation in both acute and chronic conditions
-
Improve flexibility, mobility, and tissue strength
-
Optimize post-surgical and post-injury recovery
-
Accelerate wound healing and reduce fibrosis
-
Support recovery from overtraining, microtrauma, or chronic stress
Reconstitution and Administration
Each vial contains:
-
10mg BPC-157
-
10mg TB-500
To prepare the vial for use:
-
Add 1.7mL of sterile or bacteriostatic water
Dosing Protocols
Patients can choose from three tiered protocols, depending on injury severity, recovery goals, and budget:
Option 1: Low-Dose Healing Protocol
-
Dose: 0.3mg (5 units) SubQ daily
-
Ideal for: Minor injuries, maintenance, general inflammation
-
Duration: Up to 90 days, then a mandatory 30-day break
Option 2: Standard Recovery Protocol
-
Dose: 0.6mg (10 units) SubQ daily
-
Ideal for: Moderate injuries, tendinopathy, joint issues
-
Duration: Up to 90 days, followed by 30-day rest
Option 3: High-Dose Regeneration Protocol
-
Dose: 1mg (17 units) SubQ daily
-
Ideal for: Major soft tissue injuries, post-surgical recovery, or severe inflammation
-
Duration: Up to 90 days, followed by at least 30-day break
When to Use BPC-157 + TB-500
This blend is ideal for a range of patients and scenarios, including:
-
Athletes looking to recover from training faster
-
Post-surgical patients needing accelerated healing
-
Individuals with tendinopathy, ligament sprains, or joint instability
-
Chronic pain sufferers seeking regenerative alternatives
-
Patients with gut inflammation or leaky gut (BPC-157 has GI-healing properties)
-
People with connective tissue disorders or injury-prone joints
-
Individuals experiencing inflammatory joint conditions (such as arthritis)
Expected Results
While every patient responds differently, many experience:
-
Reduced pain and inflammation within 1–2 weeks
-
Enhanced range of motion and tissue resilience
-
Accelerated recovery time from injuries or surgeries
-
Improved mobility and flexibility
-
Reduced gut permeability and inflammation (via BPC-157)
Peak results are typically seen 4–8 weeks into therapy, depending on severity and dosing.
How Long Can You Use the Combination Peptide?
Regardless of the protocol chosen, all patients should limit use to 90 consecutive days, followed by a 30-day washout period. This practice ensures peptide receptors remain responsive and minimizes risk of desensitization or reduced efficacy.
Are BPC-157 and TB-500 Safe?
While both peptides have shown remarkable safety profiles in preclinical and early clinical studies, neither is FDA-approved for human use.
At our clinic:
-
Peptides are prescribed only to current patients
-
Sourced from FDA-regulated manufacturing facilities
-
Administered under supervision by trained providers
-
Designed for research and educational purposes only
How Our Peptides Are Different
Our combination BPC-157 + TB-500 vials are:
-
Precisely dosed and pharmaceutical grade
-
Compounded in FDA-inspected cleanrooms
-
Available only to patients under medical supervision
-
Not available through online "research chemical" suppliers
-
Part of a broader, physician-directed healing protocol
Real-World Use Cases
1. Rotator Cuff Tear
A 45-year-old male with a partial rotator cuff tear avoided surgery and experienced full resolution of pain and restoration of mobility within 8 weeks using the high-dose protocol (1mg daily), combined with physical therapy and zone 2 cardio.
2. Leaky Gut Syndrome
A 34-year-old female with IBS symptoms and post-antibiotic dysbiosis completed a 90-day low-dose protocol (0.3mg daily), with notable improvement in bloating, bowel regularity, and gut-related fatigue.
3. ACL Recovery Post-Op
A 29-year-old athlete recovering from ACL repair began the standard protocol (0.6mg daily) two weeks after surgery. Surgeons noted accelerated healing, reduced swelling, and faster-than-expected rehabilitation milestones.
How to Begin Peptide Therapy
We require all prospective peptide therapy patients to complete a consultation with one of our providers. During this visit, we’ll review:
-
Medical history and injury details
-
Current medications and contraindications
-
Lab data (when appropriate)
-
Nutritional, movement, and sleep habits
We’ll then craft a personalized healing plan that may include BPC-157/TB-500 along with other regenerative therapies such as:
-
BPC-157 alone
-
TB-500 alone
-
GH secretagogues for tissue repair
-
KPV for inflammation modulation
-
PRP or Prolotherapy injections
-
Anti-inflammatory supplements like Curcumin Complex, Omega 1300, or AllerFx
Important Disclaimers
Peptides such as BPC-157 and TB-500 are:
-
Not FDA approved for treatment of any disease
-
For research purposes only
-
Intended for use under the supervision of a licensed, peptide-trained provider
-
Only available to current patients at Revolution Health
All protocols are provided strictly for educational and informational purposes and should not be used without medical guidance.
Conclusion: Harness the Power of Regenerative Healing
The combination of BPC-157 and TB-500 provides one of the most versatile and effective tools in regenerative and functional medicine today. With powerful effects on injury healing, inflammation resolution, and tissue recovery, this peptide duo is revolutionizing how we support recovery and long-term wellness.
If you're tired of chronic pain, slowed recovery, or persistent injuries, this may be the answer you've been searching for.
Ready to Begin Peptide Therapy?
📞 Call today to book a consultation and find out if BPC-157 + TB-500 is right for your needs.
🌐 Visit RevolutionHealth.org for more information or to schedule online.
Scientific References
-
Sikiric P. "BPC-157: A stable gastric pentadecapeptide protective in gastrointestinal tract and other organ systems." Curr Pharm Des. 2011.
-
Sikiric P. "BPC-157 and its role in tendon healing." J Orthop Res. 2020.
-
Goldstein AL et al. "Thymosin beta-4: A new factor for wound healing and tissue regeneration." Ann N Y Acad Sci. 2007.
-
Philp D et al. "Thymosin beta 4 promotes dermal wound repair." J Invest Dermatol. 2003.
-
Wang Y et al. "TB-500 as a potential treatment for musculoskeletal injury." Front Pharmacol. 2020.